MetLife Investment Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $233K | Hold |
|
|||||
|
2025
Q2 | $154K | Hold |
|
|||||
|
2025
Q1 | $98.5K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $77.8K | Hold |
|
|||||
|
2024
Q2 | $101K | Buy |
|
|||||
|
2024
Q1 | $111K | Hold |
|
|||||
|
2023
Q4 | $131K | Hold |
|
|||||
|
2023
Q3 | $71.2K | Hold |
|
|||||
|
2023
Q2 | $131K | Hold |
|
|||||
|
2023
Q1 | $134K | Hold |
|
|||||
|
2022
Q4 | $154K | Hold |
|
|||||
|
2022
Q3 | $136K | Hold |
|
|||||
|
2022
Q2 | $251K | Hold |
|
|||||
|
2022
Q1 | $345K | Buy |
|
|||||
|
2021
Q4 | $359K | Hold |
|
|||||
|
2021
Q3 | $495K | Hold |
|
|||||
|
2021
Q2 | $358K | Hold |
|
|||||
|
2021
Q1 | $282K | Sell |
|
|||||
|
2020
Q4 | $243K | Hold |
|
|||||
|
2020
Q3 | $162K | Buy |
|